Propylene Glycol Ethers
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The PO Production Chain and Possibilities for Energy Saving
The PO production chain and possibilities for energy saving Public Summary Report Delft, January 2012 Author(s): Ewout Dönszelmann Ab de Buck Harry Croezen Lonneke Wielders Publication Data Bibliographical data: Ewout Dönszelmann, Ab de Buck, Harry Croezen, Lonneke Wielders The PO production chain and possibilities for energy saving Public Summary Delft, CE Delft, January 2012 Energy saving / Chain Management / Products / Chemical industry / Propylene Oxide / Styrene / Iso-butylene FT: Tert-butyl alcohol (TBA) Publication code: 12.2232.12 CE publications are available from www.cedelft.eu. Commissioned by: Agentschap NL Further information on this study can be obtained from the contact person, Ewout Dönszelmann. © copyright, CE Delft, Delft CE Delft Committed to the Environment CE Delft is an independent research and consultancy organisation specialised in developing structural and innovative solutions to environmental problems. CE Delft’s solutions are characterised in being politically feasible, technologically sound, economically prudent and socially equitable. 2 January 2012 2.232.3 – The PO production chain and possibilities for energy saving Contents 1 Introduction 5 1.1 General background 5 1.2 The project 5 1.3 Approach 6 1.4 Reading guide 6 2 The production chains 7 2.1 The two processes 7 2.2 Expanded polystyrene 9 2.3 Polyols 11 2.4 TBA/iso-butylene applications 13 3 Conclusions, recommendations 17 3.1 Conclusions 17 3.2 Recommendations 17 4 Background of the Long-term Agreement Energy Efficiency ETS enterprises (LEE) 19 References 21 3 January 2012 2.232.3 – The PO production chain and possibilities for energy saving 4 January 2012 2.232.3 – The PO production chain and possibilities for energy saving 1 Introduction 1.1 General background The Dutch Industry and the Dutch government have made long term agreements on energy efficiency (LEE) for companies that are under the European Trading Scheme (ETS). -
The Toxicology of Glycol Ethers and Its Relevance to Man (Fourth Edition) Volume I
The Toxicology of Glycol Ethers and its Relevance to Man (Fourth Edition) Volume I Technical Report No. 95 ISSN-0773-8072-95 Brussels, February 2005 The Toxicology of Glycol Ethers and its Relevance to Man ECETOC TECHNICAL REPORT No. 95 © Copyright – ECETOC AISBL European Centre for Ecotoxicology and Toxicology of Chemicals 4 Avenue E. Van Nieuwenhuyse (Bte 6), B-1160 Brussels, Belgium. All rights reserved. No part of this publication may be reproduced, copied, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the copyright holder. Applications to reproduce, store, copy or translate should be made to the Secretary General. ECETOC welcomes such applications. Reference to the document, its title and summary may be copied or abstracted in data retrieval systems without subsequent reference. The content of this document has been prepared and reviewed by experts on behalf of ECETOC with all possible care and from the available scientific information. It is provided for information only. ECETOC cannot accept any responsibility or liability and does not provide a warranty for any use or interpretation of the material contained in the publication. ECETOC TR No. 95 The Toxicology of Glycol Ethers and its Relevance to Man The Toxicology of Glycol Ethers and its Relevance to Man CONTENTS - VOLUMES I AND II EXECUTIVE SUMMARY 1 SUMMARY AND CONCLUSIONS 3 Recommendations for further work 13 1. INTRODUCTION 14 1.1 Conversion factors and physico-chemical properties 14 1.2 Production and use 14 1.2.1 Manufacture of ethylene-series glycol ethers 14 1.2.2 Manufacture of propylene-series glycol ethers 15 1.2.3 Uses 15 2. -
Formulating Water-Based Systems Y,Ith Propylene-Oxide Based Glycol Ethers
Formulating Water-Based Systems y,ith Propylene-Oxide Based Glycol Ethers Carmen l. Rodriguez and Julia Weathers-lyondell Chemical Company· Bernadette Corujo-Engineered Polymer Solutions Patricia Peterson-Avecia To camply with environmental regulations, formulators have reformulated to water-based systems using non-hazardous air pollutants (non-HAP) cosolvents and developed new resin technology. In fully formulated water-based systems, however, changing the solvent system to meet environmental regulations has wide ranging effects on viscosity, surface defects, film shrinkage, adhesion, and durability. Formulators often adjust paint viscosity by balancing the levels of cosolvents, surfactants, and rheology modifiers. Reformulating with non-HAPs solvents such as propylene oxide-based glycol ethers (PG-glycol ethers) helps reduce volah1e organic content WOC) to meet environmental compliance and eliminates HAPs reporting requirements. When replacing ethylene oxide-based glycol ethers (EG-glycol ethers) with their PG-glycol ethers, reformulation seems simple enough, particularly if evaporation rates and solubility parameters are matched. A drop-in replacement, however, requires optimization. This study compares the use ofPG-glycol ethers in four architectural latex paints and assesses their effects on rheology, drying, and some key performance attributes. INTRODUCTION ing a suitable coalescent solvent for a solvent in the filmis stronglydependent waterborne coating.1 However, chang on the end use. The principal positive The primary reason for reformulating a ing the solvent package in a coating for effect of solvent entrapment is the in solventsystemis to meet environmental mulation may also necessitate optimiza creased fleXIbility of the cured coating compliance in volatile organic content tion of the other paint components. and possibly superior cure. -
Mathematical Formulation and Parametric Analysis of In
www.nature.com/scientificreports OPEN Mathematical formulation and parametric analysis of in vitro cell models in microfuidic devices: application to diferent stages of glioblastoma evolution Jacobo Ayensa‑Jiménez1,2, Marina Pérez‑Aliacar1,2, Teodora Randelovic1,2, Sara Oliván1,2, Luis Fernández1,2,3, José Antonio Sanz‑Herrera4, Ignacio Ochoa1,2,3, Mohamed H. Doweidar1,2,3 & Manuel Doblaré1,2,3* In silico models and computer simulation are invaluable tools to better understand complex biological processes such as cancer evolution. However, the complexity of the biological environment, with many cell mechanisms in response to changing physical and chemical external stimuli, makes the associated mathematical models highly non‑linear and multiparametric. One of the main problems of these models is the determination of the parameters’ values, which are usually ftted for specifc conditions, making the conclusions drawn difcult to generalise. We analyse here an important biological problem: the evolution of hypoxia‑driven migratory structures in Glioblastoma Multiforme (GBM), the most aggressive and lethal primary brain tumour. We establish a mathematical model considering the interaction of the tumour cells with oxygen concentration in what is called the go or grow paradigm. We reproduce in this work three diferent experiments, showing the main GBM structures (pseudopalisade and necrotic core formation), only changing the initial and boundary conditions. We prove that it is possible to obtain versatile mathematical tools which, together with a sound parametric analysis, allow to explain complex biological phenomena. We show the utility of this hybrid “biomimetic in vitro‑in silico” platform to help to elucidate the mechanisms involved in cancer processes, to better understand the role of the diferent phenomena, to test new scientifc hypotheses and to design new data‑driven experiments. -
2-Ethoxyethanol
2-Ethoxyethanol Product Number E 2632 Store at Room Temperature Product Description Precautions and Disclaimer Molecular Formula: C4H10O2 For Laboratory Use Only. Not for drug, household or Molecular Weight: 90.12 other uses. CAS Number: 110-80-5 Boiling point: 135 °C Preparation Instructions Melting point: -70 °C Ethylene glycol monoethyl ether is miscible with water Density: 0.931 g/ml and organic solvents. Synonyms: Ethyl glycol, Cellosolve, ethylcellosolve, ethylene glycol monoethyl ether, 2EE References 1. The Merck Index, 13th ed., Entry# 3786. 2-Ethoxyethanol is used as a component or solvent for 2. Aasmoe, L., and Aarbakke, J., Sex-dependent nitrocellulose, a wide variety of dyes, inks, cleaning induction of alcohol dehydrogenase activity in rats. agents, resins, paints, and varnishes. It is used for Biochem. Pharmacol., 57(9), 1067-1072 (1999). increasing the stability of emulsions.1 3. Hoflack, J. C., et al., Glycol ethers induce death and necrosis in human leukemia cells. Biochem. The teratogenic effects of 2EE are due to the Cell Biol., 75(4), 415-425 (1997). alkoxyacetic acid metabolites formed via the alcohol 4. Zhao, S. P., et al., Effect of simvastatin on the dehydrogenase pathway.2 The effect of 2EE on apparent size of LDL particles in patients with type human leukemic cells lines HL-60, MOLT3, and K562 IIB hyperlipoproteinemia. Clin. Chim. Acta, has been described.3 203(2-3), 109-117 (1991). 2-Ethoxyethanol has been used as a destaining Coomassie is a registered trademark of Imperial solution for lipoproteins on polyacrylamide gels stained Chemical Industries PLC. with Sudan Black B. Gels were destained with a GRS/ALF/RXR 10/03 solution of 50% ethylene glycol monoethyl ether in water for 2 hours. -
Reticulocytosis in Screen-Printing Workers Exposed to 2
Song et al. Annals of Occupational and Environmental Medicine (2017) 29:54 DOI 10.1186/s40557-017-0210-z RESEARCHARTICLE Open Access Reticulocytosis in screen-printing workers exposed to 2-butoxyethanol and 2- ethoxyethanol Seng-Ho Song, Seong-Kyu Kang*, Won-Jun Choi, Kyeong Min Kwak, Dong-Hoon Lee, Dyuk-Yoon Kang and Sang-Ha Lee Abstract Background: Studies on the hematologic toxicity of ethylene glycol ethers in humans are limited. Therefore, the aim of this study was to examine the association between exposure to solvents (containing 2-butoxyethanol and 2-ethoxyethanol) and hematological effects. Methods: Thirty-four screen-printing workers who were exposed to 2-butoxyethanol and 2-ethoxyethanol and 37 non- exposed clerical workers were selected using data from the health care facilities that provided regular health screening services. Student’s t-tests and Pearson’s chi-square tests were used to compare differences in hematological parameters between the exposed and the control groups. A multivariate analysis was performed using the multiple logistic regression models to adjust for other variables. Results: The chi-square test showed the reticulocyte percentages and corrected reticulocyte counts to be significantly higher in the exposed group. The t-tests showed a significant increase in white blood cell counts, reticulocyte percentages, and corrected reticulocyte count (i.e., reticulocyte index) in the exposed group, with p-values of 0.002, 0.004, and 0.002, respectively. Multivariate analysis showed the odds ratio for the corrected reticulocyte counts to be 16.30 for the exposed group, when compared with that of the control group. Conclusions: Exposure to 2-butoxyethanol and 2-ethoxyethanol was significantly associated with reticulocytosis, necessitating the implementation of preventive measures for workers prone to occupational exposure to ethylene glycol ethers. -
Lubricants in Pharmaceutical Solid Dosage Forms
Lubricants 2014, 2, 21-43; doi:10.3390/lubricants2010021 OPEN ACCESS lubricants ISSN 2075-4442 www.mdpi.com/journal/lubricants Review Lubricants in Pharmaceutical Solid Dosage Forms Jinjiang Li * and Yongmei Wu Drug Product Science & Technology, Bristol-Myers Squibb Corporation, 1 Squibb Dr., New Brunswick, NJ 08903, USA; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-732-227-6584; Fax: +1-732-227-3784. Received: 18 December 2013; in revised form: 21 January 2014 / Accepted: 24 January 2014 / Published: 25 February 2014 Abstract: Lubrication plays a key role in successful manufacturing of pharmaceutical solid dosage forms; lubricants are essential ingredients in robust formulations to achieve this. Although many failures in pharmaceutical manufacturing operations are caused by issues related to lubrication, in general, lubricants do not gain adequate attention in the development of pharmaceutical formulations. In this paper, the fundamental background on lubrication is introduced, in which the relationships between lubrication and friction/adhesion forces are discussed. Then, the application of lubrication in the development of pharmaceutical products and manufacturing processes is discussed with an emphasis on magnesium stearate. In particular, the effect of its hydration state (anhydrate, monohydrate, dihydrate, and trihydrate) and its powder characteristics on lubrication efficiency, as well as product and process performance is summarized. In addition, the impact of lubrication on the dynamics of compaction/compression processes and on the mechanical properties of compacts/tablets is presented. Furthermore, the online monitoring of magnesium stearate in a blending process is briefly mentioned. Finally, the chemical compatibility of active pharmaceutical ingredient (API) with magnesium stearate and its reactive impurities is reviewed with examples from the literature illustrating the various reaction mechanisms involved. -
Alcohols & Glycols Kleinschmidt
8/13/14 Alcohols," Glycols, &" “Cat”cols Kurt Kleinschmidt, MD Section Chief and Program Director, Medical Toxicology UT Southwestern Medical Center Dallas, Texas Alcohols and Glycols • “Iso” means branching of carbon chain • “Glycol” means 2 hydroxyl groups • Ethylene glycol Antifreeze • Propylene glycol Refrigerant • Polyalkylene glycol Refrigerant oil • Physiochemical behavior • If small hydrocarbon group, acts like water • If large hydrocarbon group, acts like the HC-group Alcohols and Glycols: Glycol Ethers • Clear, Syrupy liquid; Inoffensive odors; Low Vapor pressure; Non-flammable • Water & Organic soluble … Very Nice!...”Couplers”! • Do not bioaccumulate b/c undergo rapid hydrolysis • Rapid Dermal, inhalation, and oral absorption • Molecular Weight êèé Dermal absorption • Uses: Solvents Household cleaning products (windows) Humectant and plasticizer Semiconductor industry Brake fluid Diluent Deicers Paints and Coatings 1 8/13/14 Alcohols and Glycols: Glycol Ethers • Two groups: EG Monoalkyl Ethers base: • Ethylene glycol ethers R1OCH2CH2OR2 • Propylene glycol ethers R1=Alkyl gp; R2=H or Acetate • Ethylene Glycol Ethers • Many exist Ethylene Glycol • 2 examples……………. Methyl Ether (EGME) Ethers: R1-O-R2 Ethylene Glycol • Propylene Glycol Ethers Butyl Ether (EGBE) • Many • Example Is a 2o alcohol Propylene Glycol (On the 2nd Carbon) Monomethyl Ether Alcohols and Glycols: " Glycol Ethers Metabolism • ADH is key one: è Alkoxyacetic acids • Toxic Metabolite è Reproductive Problems Ethylene • Gap Acidosis Glycol • Minor route & Debatableè ethylene glycol Ether • Oxaluria seen after some methoxyethanol & butoxyethanol ingestions • But… Ether linkage is fairly stable Is No direct evidence to support Propylene • Its 2o –OH è ADH does NOT metabolize Glycol • CYP Metabolism è CO2 (Non-Toxic) Ethers • Replacing the ethylene glycol ethers Alcohols and Glycols " Clinical Glycol Ethers • Reproductive Not/Less • Animal studies è Reproduction Injury (Spont. -
Substance Name(S): 2-Ethoxyethanol EC Number: 203-804-1 CAS Number: 110-80-5
2-ETHOXYETHANOL SVHC SUPPORT DOCUMENT Substance Name(s): 2-Ethoxyethanol EC number: 203-804-1 CAS Number: 110-80-5 MEMBER STATE COMMITTEE SUPPORT DOCUMENT FOR IDENTIFICATION OF 2-ETHOXYETHANOL AS A SUBSTANCE OF VERY HIGH CONCERN BECAUSE OF ITS CMR PROPERTIES Adopted on 25 November 2010 2-ETHOXYETHANOL SVHC SUPPORT DOCUMENT CONTENTS 1 IDENTITY OF THE SUBSTANCE AND PHYSICAL AND CHEMICAL PROPERTIES ................ 4 1.1 NAME AND OTHER IDENTIFIERS OF THE SUBSTANCE ............................................................................. 4 1.2 COMPOSITION OF THE SUBSTANCE ........................................................................................................ 4 1.3 PHYSICO -CHEMICAL PROPERTIES .......................................................................................................... 5 2 HARMONISED CLASSIFICATION AND LABELLING...................................................................... 6 3 ENVIRONMENTAL FATE PROPERTIES............................................................................................. 8 4 HUMAN HEALTH HAZARD ASSESSMENT ........................................................................................ 8 4.1 TOXICITY FOR REPRODUCTION .............................................................................................................. 8 5 ENVIRONMENTAL HAZARD ASSESSMENT ..................................................................................... 8 6 CONCLUSIONS ON THE SVHC PROPERTIES .................................................................................. -
Glycol Ethers Method 2554
GLYCOL ETHERS 2554 (1) CH3OCH2CHOHCH3 MW: 90.1 CAS: 107-98-2 RTECS: UB7700000 (2) CH3OC3H6OC3H6OH 148.2 34590-94-8 JM1575000 (3) CH3OCH2CH(CH3)COOCH3 132.16 108-65-6 AI8925000 METHOD: 2554 EVALUATION: PARTIAL Issue 1: 15 March 2003 OSHA : See Table I PROPERTIES: See Table I NIOSH: See Table I ACGIH: See Table I SYNONYMS: (1) propylene glycol monomethyl ether, 1-methoxy-2-propanol, 2-methoxy-1-methylethanol, propylene glycol methyl ether (2) dipropylene glycol monomethyl ether (3) propylene glycol monomethyl ether acetate, propylene glycol methyl ether acetate, 1-methoxy-2-propyl acetate SAMPLING MEASUREMENT SAMPLER: SOLID SORBENT TUBE TECHNIQUE: GAS CHROMATOGRAPHY, FID (Anasorb® 747, 140 mg/70 mg) ANALYTE: See Table I FLOW RATE: 0.1 to 0.2 L/min DESORPTION: 1 mL of methylene chloride/methanol VOL-MIN: 3 L (85:15) for 30 minutes in ultrasonic bath -MAX: 25 L (at lower flow rates) INJECTION VOLUME: 1 :L SHIPMENT: Keep cold, pack securely for shipping TEMPERATURE SAMPLE -INJECTION: 195°C STABILITY: 14 days @ 5°C for analytes 1 and 3; -DETECTOR: 240°C 7 days @ 5°C for analyte 2 -COLUMN: 90°C (1 min) to 200°C (10°C/min) BLANKS: 2 to 10 field blanks per set CARRIER GAS: Helium, 2.8 mL/min COLUMN: Capillary, fused silica, 30 m x 0.32-mm ACCURACY ID; 100% PEG-DA, Stabilwax or equivalent RANGE STUDIED: Not determined. CALIBRATION: Solutions of analytes in desorption BIAS: Not determined. solvent Ö RANGE: (1) 1.5 to 369 :g[3] OVERALL PRECISION ( rT): Not determined. (2) 3.0 to 375 :g[3] ACCURACY: Not determined (3) 1.5 to 369 :g[3] ESTIMATED LOD: (1) 0.5 :g[3] (2) 1.0 :g[3] (3) 0.5 :g[3] þ PRECISION ( r): (1) 0.013[3] (2) 0.031[3] (3) 0.016[3] APPLICABILITY: The working range for propylene glycol monomethyl ether was 0.041 to 10.0 ppm (0.154 to 36.9 mg/m3), for dipropylene glycol monomethyl ether was 0.050 to 6.19 ppm (0.305 to 37.5 mg/m3), and propylene glycol monomethyl ether acetate was 0.030 to 6.83 ppm (0.151 to 36.9 mg/m3) for a 10 L sample . -
HPPO Process Technology a Novel Route to Propylene Oxide Without Coproducts
sustainability/ Industry perspective GREEN CHEMISTRy FRANZ SCHMIDT, MAIK BERNHARD, HEIKO MORELL, MATTHIAS PASCALy* *Corresponding author Evonik Industries AG, Advanced Intermediates – Innovation, Rodenbacher Chaussee 4, 63457 Hanau-Wolfgang, Germany Matthias Pascaly HPPO Process Technology A novel route to propylene oxide without coproducts KEYWORDS: HPPO process, propylene oxide, hydrogen peroxide, titanium silicalite. The common industrial technologies for the conversion of propylene to propylene oxide have been Abstract compared with a special focus on the direct oxidation using hydrogen peroxide. The HPPO process is an economically and ecologically superior technology since there are no market dependencies of other coproducts and water is the only waste product. The catalyst used in this process is a partly titanium substituted silica based zeolite called TS-1. The article summarizes the most important information concerning the HPPO process. INTRODUCTION approximately 7 Mt/a in the year 2010 at a production capacity of approximately 8 Mt/a. Based on a total The oxidation of organic compounds is of vital importance market growth of around 5 % per year, the expected for the chemical industry. Besides basic oxidation reactions values for demand and capacity in 2015 are nearly such as bleaching processes (e.g. paper or laundry) also at 9 and 10 Mt/a respectively. The growing markets are in oxidation reactions of chemicals are important: Epoxides Asia and potentially in the Middle East (1). - especially ethylene and propylene oxide – are among the There are several industrial routes to produce propylene major chemicals. Replacement of traditionally used halide- oxide, of which the chlorohydrin process (CH) is the based oxidants (chlorine) by hydrogen peroxide provided a oldest one (2). -
Route and Type of Formulation Administered Influences The
Journal of Functional Biomaterials Article Route and Type of Formulation Administered Influences the Absorption and Disposition of Vitamin B12 Levels in Serum Luis Vitetta 1,2,* ID , Joyce Zhou 2, Rachel Manuel 2, Serena Dal Forno 2, Sean Hall 2 ID and David Rutolo 2 1 Sydney Medical School, The University of Sydney, Sydney 2006, Australia 2 Medlab Clinical, Sydney 2015, Australia; [email protected] (J.Z.); [email protected] (R.M.); [email protected] (S.D.F.); [email protected] (S.H.); [email protected] (D.R.) * Correspondence: [email protected] or [email protected] Received: 23 December 2017; Accepted: 18 January 2018; Published: 21 January 2018 Abstract: The administration of biological compounds that optimize health benefits is an ever-evolving therapeutic goal. Pharmaceutical and other adjunctive biological compounds have been administered via many different routes in order to produce a systemic pharmacological effect. The article summarizes the findings from an Australian comparative study in adults administered vitamin B12 through different oral delivery platforms. A total of 16 subjects (9 males, 7 females) voluntarily partook in a comparative clinical study of five different vitamin B12 formulations across a six-month period, completing 474 person-hours of cumulative contribution, that was equivalent to an n = 60 participation. A nanoparticle delivered vitamin B12 through a NanoCelle platform was observed to be significantly (p < 0.05) better absorbed than all other dose equivalent platforms (i.e., tablets, emulsions, or liposomes) from baseline to 1, 3, and 6 h of the study period. The nanoparticle platform delivered vitamin B12 demonstrated an enhanced and significant absorption profile as exemplified by rapid systemic detection (i.e., 1 h from baseline) when administered to the oro-buccal mucosa with no reports of any adverse events of toxicity.